These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9621085)

  • 1. Woodchuck hepatitis virus enhancer I and enhancer II are both involved in N-myc2 activation in woodchuck liver tumors.
    Flajolet M; Tiollais P; Buendia MA; Fourel G
    J Virol; 1998 Jul; 72(7):6175-80. PubMed ID: 9621085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the N-myc2 oncogene by woodchuck hepatitis virus integration in the linked downstream b3n locus in woodchuck hepatocellular carcinoma.
    Bruni R; D'Ugo E; Giuseppetti R; Argentini C; Rapicetta M
    Virology; 1999 May; 257(2):483-90. PubMed ID: 10329558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepadnavirus integration: mechanisms of activation of the N-myc2 retrotransposon in woodchuck liver tumors.
    Wei Y; Fourel G; Ponzetto A; Silvestro M; Tiollais P; Buendia MA
    J Virol; 1992 Sep; 66(9):5265-76. PubMed ID: 1323693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The win locus involved in activation of the distal N-myc2 gene upon WHV integration in woodchuck liver tumors harbors S/MAR elements.
    Bruni R; D'Ugo E; Villano U; Fourel G; Buendia MA; Rapicetta M
    Virology; 2004 Nov; 329(1):1-10. PubMed ID: 15476869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of WHV integration nearby N-myc2 and in the downstream b3n and win loci in a considerable fraction of liver tumors with activated N-myc2 from naturally infected wild woodchucks.
    Bruni R; Conti I; Villano U; Giuseppetti R; Palmieri G; Rapicetta M
    Virology; 2006 Feb; 345(1):258-69. PubMed ID: 16271377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HNF1/HNF4-dependent We2 element of woodchuck hepatitis virus controls viral replication and can activate the N-myc2 promoter.
    Fourel G; Ringeisen F; Flajolet M; Tronche F; Pontoglio M; Tiollais P; Buendia MA
    J Virol; 1996 Dec; 70(12):8571-83. PubMed ID: 8970982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and viral trans-acting factors modulate N-myc2 promoter activity in woodchuck liver tumors.
    Flajolet M; Gegonne A; Ghysdael J; Tiollais P; Buendia MA; Fourel G
    Oncogene; 1997 Aug; 15(9):1103-10. PubMed ID: 9285565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of N-myc2 gene expression by cis-acting elements of oncogenic hepadnaviral genomes: key role of enhancer II.
    Ueda K; Wei Y; Ganem D
    Virology; 1996 Mar; 217(1):413-7. PubMed ID: 8599232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for long-range oncogene activation by hepadnavirus insertion.
    Fourel G; Couturier J; Wei Y; Apiou F; Tiollais P; Buendia MA
    EMBO J; 1994 Jun; 13(11):2526-34. PubMed ID: 8013453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scaffold attachment region located in a locus targeted by hepadnavirus integration in hepatocellular carcinomas.
    Bruni R; D'Ugo E; Argentini C; Giuseppetti R; Rapicetta M
    Cancer Detect Prev; 2003; 27(3):175-81. PubMed ID: 12787723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Woodchuck hepatitis virus DNA integration in a common chromosomal region of the woodchuck genome in two independent hepatocellular carcinomas.
    Bruni R; Argentini C; D'Ugo E; Giuseppetti R; Rapicetta M
    Arch Virol; 1997; 142(3):499-509. PubMed ID: 9349296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense downregulation of N-myc1 in woodchuck hepatoma cells reverses the malignant phenotype.
    Wang HP; Zhang L; Dandri M; Rogler CE
    J Virol; 1998 Mar; 72(3):2192-8. PubMed ID: 9499076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the woodchuck N-myc2 retroposon in brain and in liver tumors is driven by a cryptic N-myc promoter.
    Fourel G; Transy C; Tennant BC; Buendia MA
    Mol Cell Biol; 1992 Dec; 12(12):5336-44. PubMed ID: 1333041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo effects of mutations in woodchuck hepatitis virus enhancer II.
    Wei Y; Tennant B; Ganem D
    J Virol; 1998 Aug; 72(8):6608-13. PubMed ID: 9658106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple rearrangements and activated expression of c-myc induced by woodchuck hepatitis virus integration in a primary liver tumour.
    Wei Y; Ponzetto A; Tiollais P; Buendia MA
    Res Virol; 1992; 143(2):89-96. PubMed ID: 1317604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles.
    Renard CA; Fourel G; Bralet MP; Degott C; De La Coste A; Perret C; Tiollais P; Buendia MA
    Oncogene; 2000 May; 19(22):2678-86. PubMed ID: 10851067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular factors controlling the activity of woodchuck hepatitis virus enhancer II.
    Ueda K; Wei Y; Ganem D
    J Virol; 1996 Jul; 70(7):4714-23. PubMed ID: 8676498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a bidirectional promoter complex within the X gene of woodchuck hepatitis virus.
    Shimoda A; Sugata F; Chen HS; Miller RH; Purcell RH
    Virus Res; 1998 Jul; 56(1):25-39. PubMed ID: 9784063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of woodchuck hepatitis and N-myc rearrangement determine size and histologic grade of hepatic tumors.
    Jacob JR; Sterczer A; Toshkov IA; Yeager AE; Korba BE; Cote PJ; Buendia MA; Gerin JL; Tennant BC
    Hepatology; 2004 Apr; 39(4):1008-16. PubMed ID: 15057905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of WHV integration in the b3n locus in woodchuck hepatocellular carcinoma.
    Bruni R; Argentini C; D'Ugo E; Giuseppetti R; Ciccaglione AR; Rapicetta M
    Virology; 1995 Dec; 214(1):229-34. PubMed ID: 8525620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.